As of 8:05:03 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
295,451.0000
116,334.0000
75,475.0000
78,447.0000
227,547.0000
Cost of Revenue
54,422.0000
43,267.0000
26,967.0000
14,217.0000
2,392.0000
Gross Profit
241,029.0000
73,067.0000
48,508.0000
64,230.0000
225,155.0000
Operating Expense
224,574.0000
228,630.0000
228,009.0000
290,960.0000
346,551.0000
Operating Income
16,455.0000
-155,563.0000
-179,501.0000
-226,730.0000
-121,396.0000
Net Non Operating Interest Income Expense
-57,886.0000
-58,976.0000
-56,810.0000
-46,353.0000
-22,670.0000
Other Income Expense
-45,340.0000
5,291.0000
2,652.0000
3,975.0000
515.0000
Pretax Income
-86,771.0000
-209,248.0000
-233,659.0000
-269,108.0000
-143,551.0000
Net Income Common Stockholders
-86,771.0000
-209,248.0000
-233,659.0000
-269,108.0000
-143,551.0000
Diluted NI Available to Com Stockholders
-86,771.0000
-209,248.0000
-233,659.0000
-269,108.0000
-143,551.0000
Basic EPS
-0.67
-2.03
-3.52
-9.31
-5.23
Diluted EPS
-0.67
-2.03
-3.52
-9.31
-5.23
Basic Average Shares
166,401.2060
103,106.6160
66,407.2420
28,902.5070
27,473.8730
Diluted Average Shares
166,401.2060
103,106.6160
66,407.2420
28,902.5070
27,473.8730
Total Operating Income as Reported
16,455.0000
-155,563.0000
-179,501.0000
-226,730.0000
-121,396.0000
Total Expenses
278,996.0000
271,897.0000
254,976.0000
305,177.0000
348,943.0000
Net Income from Continuing & Discontinued Operation
-86,771.0000
-209,248.0000
-233,659.0000
-269,108.0000
-143,551.0000
Normalized Income
-33,536.0000
-209,248.0000
-233,659.0000
-269,108.0000
-143,551.0000
Interest Expense
57,886.0000
58,976.0000
56,810.0000
46,353.0000
22,670.0000
Net Interest Income
-57,886.0000
-58,976.0000
-56,810.0000
-46,353.0000
-22,670.0000
EBIT
-28,885.0000
-150,272.0000
-176,849.0000
-222,755.0000
-120,881.0000
EBITDA
-28,843.0000
-150,108.0000
-176,349.0000
-222,143.0000
-120,334.0000
Reconciled Cost of Revenue
54,422.0000
43,267.0000
26,967.0000
14,217.0000
2,392.0000
Reconciled Depreciation
42.0000
164.0000
500.0000
612.0000
547.0000
Net Income from Continuing Operation Net Minority Interest
-86,771.0000
-209,248.0000
-233,659.0000
-269,108.0000
-143,551.0000
Total Unusual Items Excluding Goodwill
-53,235.0000
--
--
--
--
Total Unusual Items
-53,235.0000
--
--
--
--
Normalized EBITDA
24,392.0000
-150,108.0000
-176,349.0000
-222,143.0000
-120,334.0000
12/31/2020 - 3/25/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
29A.SG Amphastar Pharmaceuticals Inc
34.66
-0.14%
27N0.DU Cannovum Cannabis AG
0.5000
+0.40%
068760.KQ Celltrion Pharm, Inc.
56,900.00
-1.22%
CRFTF BC Craft Supply Co. Ltd.
0.0001
0.00%
RIG2.BE Chemical Works of Gedeon Richter PLC
25.16
-0.55%
11L.MU Canopy Growth Corp. R
2.5700
-0.39%
R9U2.F Green Thumb Industries Inc.
7.42
+2.77%
KN0.F Dicot Pharma AB
0.0282
+20.00%
9989.HK Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3.640
-2.93%
CEL.L Celadon Pharmaceuticals Plc
14.00
-12.50%